CAS
1239875-86-5
Formulation
A crystalline solid
Purity
≥98%
MW
455,5
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
An Axl kinase inhibitor; inhibits proliferation of inflammatory breast cancer cells (IC50s = 0.43 and 0.15 µM for SUM149 and KPL-4 cells, respectively); synergistically increases the potency of erlotinib on EGFR inhibition; dose-dependently inhibits tumor growth in a mouse xenograft model of non-small cell lung cancer
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).